Search CDMOs

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

• Biologics Development & Manufacturing
• Process Development
• Quality Control Testing

Bharat Biotech is a pioneering biotechnology company specializing in vaccines and bio-therapeutics manufacturing.

• CMC Analytical Development
• Formulation Development
• Inhalation & Nasal Dosage Manufacturing

Specialist integrated CDMO with over 60 years of experience in contract development and manufacturing for pharmaceutical customers, supporting both new and off-patent drug programs.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

CDMO offering drug substance and drug product development, manufacturing, and analytical services across small molecules, peptides, and specialty chemistries.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.

• Downstream Processing
• Sterile Fill-Finish & Aseptic Manufacturing
• Formulation Development

CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Specialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules and biologics from preclinical through Phase 1 and commercialization.

• CMC Analytical Development
• Oligonucleotide Manufacturing
• Oligonucleotide

ChemGenes is a market leader in nucleic acid chemistry, specializing in the manufacturing of DNA and RNA synthesis reagents, amidites, CPG solid supports, and nucleosides.

• CMC Analytical Development
• Cell-Line Development
• Cell Therapy Manufacturing

Advanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.

• CMC Analytical Development
• Formulation Development
• HPAPI Manufacturing (High-Potency)

Metrics Contract Services, acquired by Catalent in 2024 for $475 million, operates a state-of-the-art facility in Greenville, North Carolina specializing in oral solid formulation development, manufacturing, and packaging.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Specialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Cartridge Filling

Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.